Close Menu

University of Arkansas

More With Less

Though prestigious schools get more in funding, less-prestigious schools squeeze more out of the funding they receive, an opinion piece at Bloomberg says.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

The partners aim to create a broad collection of high-quality genomic and clinical data from multiple myeloma patients to improve disease diagnosis, prognosis, and treatment.

The consortium will analyze data from patients and mouse models in the first year as part of efforts to find ways of detecting tumors earlier.

The gift will go toward the creation of theBartBarlogieCenterfor Molecular Diagnostics and the Celgene Distinguished Endowed Chair for Molecular Therapeutics.

Life Technologies of Carlsbad, Calif, has received US Patent No.

Researchers from the University of Arkansas have developed a nanopositioning system that makes use of a tuning fork, probe-bound DNA, and a solid-state nanopore to control translocation of the DNA through the pore.

IP Roundup, Jul 19, 2011

Premium

Meso Scale Technologies, California Institute of Technology, Brigham and Women's Hospital, Maven Technologies, Corning, Samsung Electronics, Affymetrix, University of Arkansas

The company plans two new versions of its MyPRS test later this year, including a pharmacogenomic enhancement called MyPRS RX and a version called MyPRS Plus that will perform myeloma subgroup analysis.

The school will use the NCRR funding to expand its Center for Protein Structure and Function.

Pages

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.